Online Program Home
  My Program

Abstract Details

Activity Number: 357 - SPEED: Biopharmaceutical Statistics
Type: Contributed
Date/Time: Tuesday, August 1, 2017 : 10:30 AM to 11:15 AM
Sponsor: Biopharmaceutical Section
Abstract #325139
Title: On the Estimation of Risk Difference in the Presence of Continuous Baseline Covariates
Author(s): Hua Ma* and Robin Mogg
Companies: Merck and Merck
Keywords: risk difference ; response rate ; baseline covariates ; clinical trials ; statistical simulation
Abstract:

Binary endpoints such as success rates or response rates have been widely used in many clinical trials. The difference in the success rates between two treatments, sometimes called the risk difference or treatment difference, is one frequently used measure of relative efficacy. The statistical methodology used to estimate the relative efficacy is becoming increasingly important, and may be complicated by the presence of categorical or continuous baseline covariates which are also associated with response. While different analysis approaches have been proposed in the literature, the selection among those approaches remains unclear to researchers in practice. In this study, through a comparison of biasness, efficiency and robustness of the estimates, a statistical simulation is conducted to investigate the performance of various methods on the estimation of risk difference in the presence of continuous baseline covariates.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2017 program

 
 
Copyright © American Statistical Association